Document Detail


Nimodipine treatment of selected good-risk patients with subarachnoid hemorrhage: no significant difference between present and historical results.
MedLine Citation:
PMID:  3413666     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Eighty-four patients were treated early with nimodipine intravenously, and thereafter orally, up to 21 days after aneurysmal subarachnoid hemorrhage. Thirty-nine patients in the nimodipine-treated group were carefully selected to be compared with similar patients from a historical control group (114 patients) conventionally treated. The causes of poor results were clinically identified as follows: delayed ischemic deterioration (DID), rebleeding, complications of surgery, or not defined. There was no significant difference in the distribution of DID or outcome at follow-up examination (at least 6 months later) between the nimodipine-treated group and the control group.
Authors:
L Pellettieri; H Bolander; H Carlsson; U Sjölander
Related Documents :
18602846 - Systematic review of utilities in abdominal aortic aneurysm.
18380986 - Hyperglycemia in patients undergoing cerebral aneurysm surgery: its association with lo...
20395616 - Life events and risk of subarachnoid hemorrhage: the australasian cooperative research ...
15595346 - Pathogenesis, natural history, and treatment of unruptured intracranial aneurysms.
20498216 - Beneficial effect of 1-year etanercept treatment on the lipid profile in responding pat...
16151286 - The long-term analgesic efficacy of a single-shot fascia iliaca compartment block in bu...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Surgical neurology     Volume:  30     ISSN:  0090-3019     ISO Abbreviation:  Surg Neurol     Publication Date:  1988 Sep 
Date Detail:
Created Date:  1988-10-05     Completed Date:  1988-10-05     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0367070     Medline TA:  Surg Neurol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  180-6     Citation Subset:  IM    
Affiliation:
Department of Neurosurgery, University Hospital, Uppsala, Sweden.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Adult
Brain Ischemia / drug therapy,  physiopathology,  prevention & control
Child
Child, Preschool
Follow-Up Studies
Humans
Hypertension / complications
Infant
Infant, Newborn
Intracranial Aneurysm / complications,  surgery
Ligation
Middle Aged
Nimodipine / therapeutic use*
Risk Factors
Subarachnoid Hemorrhage / drug therapy*,  etiology,  surgery
Time Factors
Chemical
Reg. No./Substance:
66085-59-4/Nimodipine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Endoscopic percutaneous cecostomy (EPC).
Next Document:  Epithelial cells in symptomatic Rathke's cleft cysts. A light- and electron-microscopic study.